USA - NYSE:ZTS - US98978V1035 - Common Stock
We assign a fundamental rating of 7 out of 10 to ZTS. ZTS was compared to 191 industry peers in the Pharmaceuticals industry. While ZTS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ZTS is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.04% | ||
| ROE | 52.48% | ||
| ROIC | 25.36% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 37.69% | ||
| PM (TTM) | 27.83% | ||
| GM | 71.5% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 2.97 | ||
| Altman-Z | 7.01 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.04 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.67 | ||
| Fwd PE | 21.2 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.4 | ||
| EV/EBITDA | 17.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.31% |
NYSE:ZTS (10/24/2025, 10:12:10 AM)
147.22
+0.83 (+0.57%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.67 | ||
| Fwd PE | 21.2 | ||
| P/S | 6.95 | ||
| P/FCF | 29.4 | ||
| P/OCF | 22.28 | ||
| P/B | 13.11 | ||
| P/tB | 57.03 | ||
| EV/EBITDA | 17.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.04% | ||
| ROE | 52.48% | ||
| ROCE | 31.83% | ||
| ROIC | 25.36% | ||
| ROICexc | 29.12% | ||
| ROICexgc | 48.22% | ||
| OM | 37.69% | ||
| PM (TTM) | 27.83% | ||
| GM | 71.5% | ||
| FCFM | 23.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 2.97 | ||
| Debt/EBITDA | 1.3 | ||
| Cap/Depr | 146.09% | ||
| Cap/Sales | 7.57% | ||
| Interest Coverage | 12.96 | ||
| Cash Conversion | 72.81% | ||
| Profit Quality | 84.95% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 7.01 |
ChartMill assigns a fundamental rating of 7 / 10 to ZTS.
ChartMill assigns a valuation rating of 5 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.
ZOETIS INC (ZTS) has a profitability rating of 9 / 10.
The Price/Earnings (PE) ratio for ZOETIS INC (ZTS) is 23.67 and the Price/Book (PB) ratio is 13.11.
The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 8.48% in the next year.